Sonendo

Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. It offers practice management software to enable an integrated digital office for dental practitioners. The company was founded by Olav B. Bergheim in 2006 and is headquartered in Laguna Hills, CA.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Sonendo reports robust Q4 earnings, eyes GP market expansion

Sonendo's Q4 2022 performance reflects strong revenue growth, milestone achievements, and strategic initiatives aimed at driving profitability and market expansion.
The company's focus on innovation, pricing strategies, and market diversification positions it well for sustained growth and competitive advantage in the dental technology sector.
While facing challenges in adoption transitions and market expansion, Sonendo has opportunities to capitalize on product innovation, market expansion, and strategic investments for future success.
Overall, Sonendo's performance, strengths, challenges, and opportunities indicate a positive outlook for continued growth, profitability, and market leadership in the dental technology industry.

Sonendo reports robust Q1 performance, eyes growth in GP market

Sonendo's Q1 2023 performance showed strong revenue growth and improved gross margins.
The company is capitalizing on the market interest in GentleWave consoles, especially the new G4 systems.
Challenges include longer sales cycles and the need to adapt to changing customer mindsets.
Opportunities lie in expanding market reach among general practitioners and enhancing operational efficiencies.

Sonendo reports $11M revenue in Q2 2023, focuses on margin improvement

Sonendo's Q2 2023 performance showed revenue growth driven by PI sales but offset by declining console revenue, with a focus on margin improvement and expense management.
Strengths include strong PI sales growth, initiatives to enhance margins, and strategic efforts to educate GPs about the GentleWave procedure.
Challenges include declining console placements, expense management actions, and revised revenue guidance due to sales cycle elongation.
Opportunities lie in leveraging PI sales growth, educating GPs, improving margins, and adapting to market dynamics for future growth and profitability.

Sonendo reports revenue growth amidst challenges, eyes market expansion

Sonendo's Q3 performance showed revenue growth but with high operating expenses.
The company is focusing on revenue growth, margin improvement, and cash preservation.
Challenges include declining consumable sales and ongoing debt covenant discussions.
Opportunities lie in market expansion, margin enhancement, and cost reduction efforts.

Sonendo reports mixed Q4 results, sets ambitious targets for 2024

Sonendo's 2023 performance showed revenue growth and margin improvement, with strategic divestments and debt restructuring enhancing financial flexibility.
While facing challenges in specific product sales and cost management, the company aims to capitalize on growth opportunities in 2024.
Clear communication on guidance, margins, and strategies can position Sonendo for sustainable growth and profitability in the coming year.

Sonendo exceeds Q1 revenue target, focuses on margin expansion

Sonendo's Q1 2024 earnings call highlighted a solid performance, operational strengths, challenges in revenue diversification, and opportunities for growth.
The company's focus on cost-saving measures, margin expansion, and strategic initiatives positions them well for future success and market competitiveness.
Investors should monitor Sonendo's execution of their strategic plan and revenue diversification efforts to assess long-term sustainability and growth potential.

Sonendo reports strong Q2 performance, raises revenue guidance

Sonendo's Q2 2024 performance reflects positive momentum and strategic alignment with growth objectives.
The company's focus on innovation, cost optimization, and revenue growth positions it well for future success.
While challenges exist, Sonendo's proactive approach and market opportunities bode well for sustained performance.
Overall, Sonendo's financial health and operational improvements signal a promising outlook for investors.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Sonendo, Inc. is a medical technology company, which developed and manufactures the GentleWave System to treat tooth decay. It operates through the Product and Software segments. The Product segment includes the sales of the GentleWave System console and related accessories and instruments. The Software segment focuses on the sales of traditional software licenses for practice management software to enable an integrated digital office for endodontists. The company was founded by Olav B. Bergheim in June 2006 and is headquartered in Laguna Hills, CA.

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today announced a partnership agreement with Dental Purchasing Group (DPG), a member-driven group purchasing organization (GPO) that provides independent and group dental practices with cost savings programs. As a result of the agreement, DPG members can adopt and implement the GentleWave Procedure into their practices to provide their patients with el.

Sonendo Continues Expanding the Reach of Its GentleWave Procedure; Partners with Dental Purchasing Group

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today announced a partnership agreement with BEST for Dentistry, a dental services company focused on leveling the playing field for independent dental practices. The goal of this strategic alliance is to expand access to the GentleWave Procedure, which offers a less invasive and less painful alternative to traditional root canal therapy, by making it.

Sonendo Partners With BEST for Dentistry to Continue Expanding Access to the Innovative GentleWave® Procedure

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX) (“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, today announced that, on November 15, 2023, it received a notice from the New York Stock Exchange (the “NYSE”) that the Company was no longer in compliance with the NYSE continued listing standards set forth in Section 802.01B of the NYSE's Listed Company Manual (“Section 802.01B”) due to the Company's average global market.

Sonendo, Inc. Announces Suspension of NYSE Trading, Will Commence Trading on the OTCQX Effective November 22, 2023

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Sonendo, Inc. (the “Company”) — ticker symbol SONX — from the NYSE. Trading in the Company's common stock will be suspended immediately. NYSE Regulation reached its decision to delist the Company's common stock pursuant to Section 802.01B of the NYSE's Listed Company Manual because the Company had f.

NYSE to Commence Delisting Proceedings Against Sonendo, Inc. (SONX)

Sonendo, Inc. (NYSE:SONX ) Q3 2023 Results Conference Call November 8, 2023 4:30 PM ET Company Participants Louisa Smith - Gilmartin Group Bjarne Bergheim - President & Chief Executive Officer Michael Watts - Chief Financial Officer Conference Call Participants Tom Stephan - Stifel Jason Bednar - Piper Sandler Justin Wang - Morgan Stanley Operator Hello, and welcome to Sonendo's Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.

Sonendo, Inc. (SONX) Q3 2023 Earnings Call Transcript

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the third quarter ended September 30, 2023. Recent Highlights Total revenue of $10.4 million for the third quarter of 2023, representing growth of 6%, compared to prior year period Reduced cash burn to approximately $10 million in the third quarter of 2023; additionally, implemented reduction in force in November 2023.

Sonendo, Inc. Reports Third Quarter 2023 Financial Results

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will participate in three upcoming investor conferences in November. Sonendo management is scheduled to present at the Stifel 2023 Healthcare Conference on Tuesday, November 14th at 6:10 a.m. Pacific Time / 9:10 a.m. Eastern Time. Sonendo management is scheduled to present at the 2023 Sidoti Micro Cap Conference on Wednes.

Sonendo to Participate at Upcoming November Investor Conferences

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”) (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the third quarter 2023 after the market close on Wednesday, November 8th, 2023. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may do so by d.

Sonendo, Inc. to Report Third Quarter 2023 Financial Results on November 8, 2023

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced its first Root Canal Forum for General Dentists, an educational and networking experience created by clinicians, for clinicians aimed at increasing adoption of the GentleWave System. Taking place in Nashville from Oct. 20-21, this two-day forum is designed to support the advancement of endodontic treatment in the general practice by prov.

Sonendo Announces Inaugural Root Canal Forum for General Dentists

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo” or the "Company") (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced certain unaudited preliminary financial results for the third quarter ended September 30, 2023. Unaudited Preliminary Third Quarter 2023 Financial Results Total revenue is expected to be approximately $10.4 million for the third quarter 2023. Cash, cash equivalents and short-term investments as of September 3.

Sonendo, Inc. Announces Preliminary Revenue Results for the Third Quarter 2023

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced its third EndoCon, a comprehensive program covering the latest in endodontic technology and innovation. Taking place in San Diego at the Manchester Grand Hyatt from Oct. 5-7, the three-day event will offer lectures, workshops and training sessions for clinicians, staff and postgrad residents. Offering something for everyone, EndoCon will.

Sonendo Announces EndoCon 2023, An Endodontic Conference on Practice Growth

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced the signing of two new strategic partnership agreements with the country's leading endodontic dental service organizations (DSOs) to expand patient access to a best-in-class root canal experience. As a result of these partnerships, the GentleWave System with CleanFlow™ Technology, which offers a less invasive and less painful alternative.

Sonendo Announces New Partnership Agreements with Two Leading Specialty DSOs to Expand Access to the GentleWave® Procedure for Elevated Root Canal Treatment

Sonendo (NYSE: SONX ) stock is on the rise Wednesday despite the medical technology company recently receiving a delisting notice. That notice comes from the New York Stock Exchange and has to do with the price of SONX stock.

Why Is Sonendo (SONX) Stock Up 38% Today?

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX) (“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, today announced that on September 28, 2023, it received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with applicable price criteria in the NYSE's continued listing standard set forth in the NYSE Listed Company Manual because the average closing price of the Company.

Sonendo, Inc. Announces Receipt of Notice of Non-Compliance with NYSE Trading Share Price Listing Rule

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced the launch of its second generation CleanFlow™ Procedure Instrument. The updated procedure instrument now includes an optimized design and enhanced matrix system to improve the effectiveness and ease of use of the GentleWave Procedure. This redesigned matrix facilitates a more congruent, secure and lasting seal which provides a heightene.

Sonendo Announces Launch of Second Generation CleanFlow™ Procedure Instrument for Heightened Efficacy and Ease of Use

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that on September 25, 2023, the Compensation Committee of Sonendo's Board of Directors granted restricted stock unit awards covering an aggregate of 14,000 shares of its common stock to two new, non-executive employees to induce them to join the company. The awards were granted under Sonendo's 2023 Employment Inducement Incentive Award P.

Sonendo, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will participate in the upcoming LD Micro Main Event XVI Conference. Management is scheduled to present on Wednesday, October 4th at 2:30 p.m. Pacific Time/ 5:30 p.m. Eastern Time. A webcast of the presentation will be available on the “Investors” section of the company's website at: investor.sonendo.com. About Sonendo So.

Sonendo to Participate at the LD Micro Main Event XVI Conference

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will participate in the upcoming Gilmartin Group Emerging Growth Company Showcase. Management is scheduled to present on Thursday, September 21st at 9:00 a.m. Pacific Time/ 12:00 p.m. Eastern Time. A webcast of the presentation will be available on the “Investors” section of the company's website at: investor.sonendo.com.

Sonendo to Participate at the Gilmartin Group Emerging Growth Company Showcase

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced it is hosting the second Women in Endodontics summit. Taking place in Tucson, Ariz. at the Miraval Resort from Sept. 14-16, the event aims to support leadership and both personal and professional growth through education and peer connection. Now in its second year, Women in Endodontics brings together world-renowned speakers and industry.

Sonendo Hosts Second Women in Endodontics Summit

Sonendo, Inc. (NYSE:SONX ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Louisa Smith - Gilmartin Group Bjarne Bergheim - President & Chief Executive Officer Michael Watts - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Sarah Conrad - Goldman Sachs Joe Federico - Stifel Operator Good afternoon and welcome to Sonendo's Second Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.

Sonendo, Inc. (SONX) Q2 2023 Earnings Call Transcript

Sonendo, Inc. (SONX) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.57 per share a year ago.

Sonendo, Inc. (SONX) Reports Q2 Loss, Misses Revenue Estimates

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the quarter ended June 30, 2023. Recent Highlights Total revenue of $11.0 million for the second quarter of 2023, representing growth of 5%, compared to prior year period Procedure instrument revenue of $5.6 million for the second quarter of 2023, representing growth of approximately 16% compared to prior year period.

Sonendo, Inc. Reports Second Quarter 2023 Financial Results

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced enhancements to its CleanFlow™ Procedure Instrument, which are designed to improve its applicability and effectiveness. The CleanFlow Procedure Instrument can now be used on anterior teeth (the teeth located at the front of the mouth), replacing the Company's legacy APM (Anterior Pre-Molar) Procedure Instrument. “We launched CleanFlow Te.

Sonendo's Enhanced CleanFlow™ Procedure Instrument Now Indicated for Use on Anterior Teeth

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”) (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the second quarter 2023 after the market close on Wednesday, August 9th, 2023. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may do so by di.

Sonendo, Inc. to Report Second Quarter 2023 Financial Results on August 9, 2023

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced the publication of a new study that found the GentleWave System to be significantly more effective than conventional irrigation methods at dissolving tissue during root canal procedures. An essential, yet challenging step in the root canal procedure process, tissue removal is a key indicator of efficacy and how quickly the root canal sys.

News for Sonendo Stock (SONX)